Data as of Dec 18
| +0.0388 / +4.52%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 2.70. The median estimate represents a +234.22% increase from the last price of 0.90.
The current consensus among 8 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.